Folares Pharmaceuticals Prevails as Court Cancels Deficiency Tax Assessments
Court cancels Folares Pharmaceuticals’ 2017 tax assessments, citing BIR’s failure to comply with due process requirements in issuing PAN and FLO/FAN. Taxpayers now have a reinforced reminder that due process is non-negotiable in internal revenue assessments. Folares Pharmaceuticals Inc. successfully challenged deficiency income tax, VAT, expanded withholding tax, improperly accumulated earnings tax (IAET), and compromise […]